# Malignant Pleural Effusion: Pleur-X vs. Chemical Pleurodesis in VATS

> **NCT03518788** · NA · UNKNOWN · sponsor: **Rolf Inderbitzi** · enrollment: 234 (estimated)

## Conditions studied

- Malignant Pleural Effusion

## Interventions

- **PROCEDURE:** Pleur-X
- **PROCEDURE:** Pleurodesis

## Key facts

- **NCT ID:** NCT03518788
- **Lead sponsor:** Rolf Inderbitzi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-25
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 234 (ESTIMATED)
- **Last updated:** 2018-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03518788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03518788, "Malignant Pleural Effusion: Pleur-X vs. Chemical Pleurodesis in VATS". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT03518788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*